Literature DB >> 28784433

Anticandidal activity of ethanolic root extract of Juglans regia (L.): Effect on growth, cell morphology, and key virulence factors.

V Raja1, S I Ahmad1, M Irshad2, W A Wani3, W A Siddiqi1, S Shreaz4.   

Abstract

The emergence of drug-resistant strains has encouraged several studies on natural products with antifungal activity and low toxicity. In this study, the antifungal effect of methanolic root extract of Juglans regia (JRE) was investigated against 9 strains of Candida (one reference and 8 clinical strains) through MIC90 and spot assays. To gain insight into the mechanism of antifungal action, we carried out confocal scanning laser microscopy (CLSM), transmission electron microscopy (TEM), and then examined the effect of JRE on hydrolytic enzyme secretion. Additionally, JRE was subjected to various phytochemical tests, chemically characterized by gas chromatography-mass spectrometry analysis (GC-MS) and its toxicity was tested against H9c2 rat cardiac myoblasts. The phytochemical tests showed the presence of phenols, alkaloids, steroids, saponins, and tannins in JRE. In the GC-MS analysis, a total of 40 compounds were identified. JRE was found to be effective in liquid media with MICs ranging from 300 to 700μg/mL. Spot assay results revealed that Candida cells show increased sensitivity to JRE. CSLM experiments showed that cells exposed to JRE (MIC) exhibited cell membrane disruption. TEM micrograph of treated cells showed extensive breakage in the cell wall and cell membrane. Average inhibition of proteinase and phospholipase secretion (of five C. albicans strains) at MIC/2 values of JRE was 45.17%, and 34.29%, respectively. Cellular toxicity of JRE against H9c2 rat cardiac myoblasts was less than 10% at the highest MIC value. These findings encourage further development of JRE.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Candida albicans; Electron microscopy; Hydrolytic enzymes; Juglans regia

Mesh:

Substances:

Year:  2017        PMID: 28784433     DOI: 10.1016/j.mycmed.2017.07.002

Source DB:  PubMed          Journal:  J Mycol Med        ISSN: 1156-5233            Impact factor:   2.391


  6 in total

1.  Antimicrobial, Antioxidant, and Cytotoxic Activities of Juglans regia L. Pellicle Extract.

Authors:  Floriana D'Angeli; Giuseppe Antonio Malfa; Adriana Garozzo; Giovanni Li Volti; Carlo Genovese; Aldo Stivala; Daria Nicolosi; Francesco Attanasio; Francesco Bellia; Simone Ronsisvalle; Rosaria Acquaviva
Journal:  Antibiotics (Basel)       Date:  2021-02-04

Review 2.  A Comprehensive Review on the Chemical Constituents and Functional Uses of Walnut (Juglans spp.) Husk.

Authors:  Ali Jahanban-Esfahlan; Alireza Ostadrahimi; Mahnaz Tabibiazar; Ryszard Amarowicz
Journal:  Int J Mol Sci       Date:  2019-08-12       Impact factor: 5.923

Review 3.  A Comparative Review on the Extraction, Antioxidant Content and Antioxidant Potential of Different Parts of Walnut (Juglans regia L.) Fruit and Tree.

Authors:  Ali Jahanban-Esfahlan; Alireza Ostadrahimi; Mahnaz Tabibiazar; Ryszard Amarowicz
Journal:  Molecules       Date:  2019-06-05       Impact factor: 4.411

Review 4.  Targeting Virulence Factors of Candida albicans with Natural Products.

Authors:  Qing-Ru Bu; Meng-Yuan Bao; Yue Yang; Tian-Ming Wang; Chang-Zhong Wang
Journal:  Foods       Date:  2022-09-21

5.  Green Ultrasound versus Conventional Synthesis and Characterization of Specific Task Pyridinium Ionic Liquid Hydrazones Tethering Fluorinated Counter Anions: Novel Inhibitors of Fungal Ergosterol Biosynthesis.

Authors:  Nadjet Rezki; Salsabeel A Al-Sodies; Sheikh Shreaz; Rayees Ahmad Shiekh; Mouslim Messali; Vaseem Raja; Mohamed R Aouad
Journal:  Molecules       Date:  2017-11-07       Impact factor: 4.411

6.  Analysis of Plant Origin Antibiotics against Oral Bacterial Infections Using In Vitro and In Silico Techniques and Characterization of Active Constituents.

Authors:  Abdul Rafey; Adnan Amin; Muhammad Kamran; Uzma Haroon; Kainat Farooq; Kenn Foubert; Luc Pieters
Journal:  Antibiotics (Basel)       Date:  2021-12-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.